TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Takara Bio Inc. ( (JP:4974) ) has provided an announcement.
Takara Bio Inc. reported a decrease in net sales for the nine months ending December 31, 2024, with a notable decline in operating and ordinary profits compared to the previous year. Despite declining performance in the interim period, the company has revised its full-year forecast, anticipating a modest recovery in sales and profits by the end of the fiscal year, signaling a potential stabilization in its financial health.
More about Takara Bio Inc.
Takara Bio Inc. is a company listed on the Tokyo Stock Exchange with a focus on biotechnology. It specializes in the development and distribution of products and services related to genetic engineering, including reagents and kits for gene amplification and detection.
YTD Price Performance: -4.29%
Average Trading Volume: 167,496
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: Yen121B
Find detailed analytics on 4974 stock on TipRanks’ Stock Analysis page.